Clinical Trial Update: Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating ciprofloxacin in combination with Escherichia coli Nissle 1917 for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Escherichia coli Nissle 1917 (Escherichia coli Nissle 1917)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Ulcerative Colitis | Phase 4 | Status: COMPLETED